We continue to actively monitor the coronavirus situation. Learn about the steps we are taking to ensure your safety and get answers to some common questions.

Jeff Snodgrass


As President of Azura Vascular Care, Jeff Snodgrass oversees all the company’s business activities providing executive leadership and strategic guidance across the vascular division of Fresenius Medical Care North America. Jeff joined Fresenius Vascular Care in April 2013 as Vice President of Finance and led the finance team through a period of significant change and growth, developed a collaborative approach with Operations resulting in overall improvement in performance. Jeff also led the Business Development group, which has closed several acquisitions and developed a pipeline of potential acquisitions and de novos. Today, Jeff is leading Azura Vascular through the transformation of its Vascular Access Centers to Ambulatory Surgical Centers.

Jeff’s career spans for more than 30 years with experience in domestic finance, strategy and general management. Prior roles include Jeff having served as Chief Financial Officer at Inventiv Health, and various financial leadership positions at Merck & Co. for more than 17 years. His last role at Merck was as the VP Finance and Controller for the company’s global research and development organization.